New molecular approches using AR, FOXA1 and HER2 for outcome classification of estrogen Receptor-Positive (ER+) breast cancers”
Here, we studied new prognostic and predictive easy access strategies in breast cancer (molecular markers), for better classify ER+ breast cancer disease, which might provide additional information and be complementary to the clasical clinical-pathological prediction models.
| Autor Principal: | |
|---|---|
| Otros Colaboradores: | |
| Formato: | Tesis de doctorado (Doctoral Thesis) |
| Lenguaje: | Español (Spanish) |
| Publicado: |
Universidad del Rosario
2018
|
| Materias: | |
| Acceso en línea: | http://repository.urosario.edu.co/handle/10336/18932 https://doi.org/10.48713/10336_18932 |